BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16466564)

  • 1. Nationwide quality assurance of rectal cancer treatment.
    Wibe A; Carlsen E; Dahl O; Tveit KM; Weedon-Fekjaer H; Hestvik UE; Wiig JN;
    Colorectal Dis; 2006 Mar; 8(3):224-9. PubMed ID: 16466564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and outcomes in patients with advanced rectal cancer: a national prospective cohort study.
    Sigurdsson HK; Körner H; Dahl O; Skarstein A; Søreide JA;
    Dis Colon Rectum; 2007 Mar; 50(3):285-91. PubMed ID: 17235720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of hospital caseload on long-term outcome after standardization of rectal cancer surgery at a national level.
    Wibe A; Eriksen MT; Syse A; Tretli S; Myrvold HE; Søreide O;
    Br J Surg; 2005 Feb; 92(2):217-24. PubMed ID: 15584060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Quality registry for better treatment of rectal cancer established. Economical support is required to use the benefits of the information].
    Bohe M; Cedermark B; Damber L; Lewin F; Lindmark G; Nordgren S; Påhlman L; Sjödahl R
    Lakartidningen; 2000 Aug; 97(34):3587-8, 3591. PubMed ID: 11036378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of treatment in routine care in a population sample of rectal cancer patients.
    Engel J; Kerr J; Eckel R; Günther B; Heiss M; Heitland W; Jauch KW; Siewert JR; Hölzel D
    Acta Oncol; 2005; 44(1):65-74. PubMed ID: 15848908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rectal cancer in the young patient.
    Endreseth BH; Romundstad P; Myrvold HE; Hestvik UE; Bjerkeset T; Wibe A;
    Dis Colon Rectum; 2006 Jul; 49(7):993-1001. PubMed ID: 16741599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of radiotherapy on local recurrence of rectal cancer in Norway.
    Hansen MH; Kjaeve J; Revhaug A; Eriksen MT; Wibe A; Vonen B;
    Br J Surg; 2007 Jan; 94(1):113-8. PubMed ID: 17083107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curative rectal cancer surgery in a low-volume hospital: a quality assessment.
    Debes AJ; Størkson RH; Jacobsen MB
    Eur J Surg Oncol; 2008 Apr; 34(4):382-9. PubMed ID: 17669613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision.
    Laurent C; Nobili S; Rullier A; Vendrely V; Saric J; Rullier E
    J Am Coll Surg; 2006 Nov; 203(5):684-91. PubMed ID: 17084330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rectal cancer treatment of the elderly.
    Endreseth BH; Romundstad P; Myrvold HE; Bjerkeset T; Wibe A;
    Colorectal Dis; 2006 Jul; 8(6):471-9. PubMed ID: 16784465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of total mesorectal excision on local recurrence and survival in rectal cancer patients: a population-based study in Greater Amsterdam.
    Visser O; Bakx R; Zoetmulder FA; Levering CC; Meijer S; Slors JF; van Lanschot JJ
    J Surg Oncol; 2007 May; 95(6):447-54. PubMed ID: 17048237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender differences in the treatment of rectal cancer: a population based study.
    Martling A; Granath F; Cedermark B; Johansson R; Holm T
    Eur J Surg Oncol; 2009 Apr; 35(4):427-33. PubMed ID: 18436417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic groups in 1,676 patients with T3 rectal cancer treated without preoperative radiotherapy.
    Eriksen MT; Wibe A; Haffner J; Wiig JN;
    Dis Colon Rectum; 2007 Feb; 50(2):156-67. PubMed ID: 17180256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence on treatment outcome of structuring rectal cancer care.
    Påhlman L; Gunnarsson U; Karlbom U
    Eur J Surg Oncol; 2005 Aug; 31(6):645-9. PubMed ID: 15893909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is pre-operative radiotherapy necessary in T-T rectal cancer with TME?
    Mackay G; Downey M; Molloy RG; O'Dwyer PJ
    Colorectal Dis; 2006 Jan; 8(1):34-6. PubMed ID: 16519635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma.
    Peeters KC; Marijnen CA; Nagtegaal ID; Kranenbarg EK; Putter H; Wiggers T; Rutten H; Pahlman L; Glimelius B; Leer JW; van de Velde CJ;
    Ann Surg; 2007 Nov; 246(5):693-701. PubMed ID: 17968156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of total mesorectal excision and preoperative chemoradiotherapy on local recurrence in rectal cancer].
    Wu AW; Gu J; Wang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 May; 9(3):207-9. PubMed ID: 16721678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical outcomes after total mesorectal excision for rectal cancer.
    Chiappa A; Biffi R; Bertani E; Zbar AP; Pace U; Crotti C; Biella F; Viale G; Orecchia R; Pruneri G; Poldi D; Andreoni B
    J Surg Oncol; 2006 Sep; 94(3):182-93; discussion 181. PubMed ID: 16900534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inadvertent perforation during rectal cancer resection in Norway.
    Eriksen MT; Wibe A; Syse A; Haffner J; Wiig JN; ;
    Br J Surg; 2004 Feb; 91(2):210-6. PubMed ID: 14760670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of postoperative complications on long-term outcomes following curative resection for colorectal cancer.
    Law WL; Choi HK; Lee YM; Ho JW
    Ann Surg Oncol; 2007 Sep; 14(9):2559-66. PubMed ID: 17522945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.